| abstract |
The present invention relates to a combination comprising acetylsalicylic acid (component A) with an HMG-CoA reductase inhibitor (component B), which is optionally additionally supplemented with an antihypertensive substance (component C), for the primary prevention of cardiovascular diseases in patients who have an increased risk of developing cardiovascular disease, medicines containing this combination, and methods for their production. |